PCV68 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO...

PCV68 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO RECLASSIFY PATIENTS WITH AN INTERMEDIATE RISK BASED ON THE FRAMINGHAM RISK SCORE INTO A LOWER OR HIGHER CATEGORY TO OPTIMIZE STATIN THERAPY

LT Burgers, WK Redekop, JL Severens
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72411-1
File:
PDF, 79 KB
english, 2010
Conversion to is in progress
Conversion to is failed